Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
Quarterback 2 - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer
Prospective Registration of Head and Neck Cancer
Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
† Study has passed its completion date and status has not been verified in more than two years.